Congenital Chagas Test

About Kephera Diagnostics

Kephera Diagnostics is a commercial-stage, private diagnostics company targeting significant unmet needs in infectious diseases and women's health. Its core strategy involves developing novel immunoassays, including point-of-care and ELISA formats, and offering them through its own certified clinical laboratory. The company has launched several first-to-market tests, including a blood-based diagnostic for endometriosis (EndomTest™) and comprehensive panels for parasitic infections like Chagas disease and liver fluke, supported in part by NIH grants. Kephera's model combines proprietary test development with a revenue-generating laboratory services business.

Therapeutic Areas